Send feedback

RAG1 p.Ser259fs

c.775del · rs878853031 · VCV235411

Pathogenic Expert panel
Classification
Pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 8 submitters
Consequence
frameshift
predicted LoF
gnomAD v4.1
Rare
very rare (popmax 0.000593%, nfe)
Conditions
5
recombinase activating gene 1 deficiency

ClinGen expert panel — Severe Combined Immunodeficiency Disease VCEP

Pathogenic for recombinase activating gene 1 deficiency. Applied ACMG criteria (verbatim):

PVS1 PM3_Supporting PM2_Supporting

Curation rationale (ClinGen, verbatim)

The nonsense variant NM_000448.3(RAG1):c.775del (p.Ser259AlafsTer5) occurs in exon 2 of 2 (the only coding exon of RAG1) and is not predicted to result in nonsense mediated decay but does truncate 75% of the protein, including the entirety of the core domain (amino acids 387-1011) which is critical to protein function (PMID: 26996199; PVS1). This variant is absent from gnomADv2.1.1 (PM2_Supporting). It has been reported homozygous in one patient with Omenn syndrome (PM3_supporting) with insufficient information to determine that the patient's phenotype is highly specific to recombinase activating gene 1 deficiency (PP4_NotMet). In summary, this variant meets the criteria to be classified as pathogenic for recombinase activating gene 1 deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP. Criteria applied: PVS1, PM3_Supporting, and PM2_Supporting. (VCEP specifications version 1).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequenceframeshiftpredicted loss-of-function
NMDescapespremature termination codon in the last exon (2 of 2) — the truncated protein is likely expressed. PVS1 input, not an applied code
Splicing
SpliceAI—not assessed · substitutions only
Constraint at this position
ConservationphyloP -3.2GERP -1.8

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000593% European (non-Finnish) · 7/1,180,022 alleles
Filtering AF 0.000247% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000159%
Overall 0.000496% 8/1,614,144 alleles · very rare exomes 8/1,461,858 · genomes 0/152,286 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0016% 62,504
European (non-Finnish)grpmax 0.000593% 168,575

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
RAG1
Protein
p.Ser259fs
Coding
c.775del
MANE Select
NM_000448
dbSNP
rs878853031
Type
Deletion
Location
chr11:36574079 (GRCh38)
Gene constraint
LOEUF 0.703 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 81.68
Residue 259
the 'interaction with importin alpha-1' region
Full RAG1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/rag1-p-ser259fs (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown